Biopharmaceutical solutions provider Syneos Health has reached a strategic collaboration with AI and advanced data analytics provider AiCure.
The partnership is aimed at creating smarter clinical trials for patient engagement optimisation.
Go deeper with GlobalData
It also strives to meet customer demand for digital solutions to enhance patients’ lives.
The collaboration enables AiCure to leverage its proprietary intelligent software and AI-driven solutions.
It also captures and analyses Syneos Health’s behavioural insights-driven product development model, which impact clinical trial adherence.
Syneos Health CEO Alistair Macdonald said: “The AiCure platform aligns with our unique product development model that harnesses behavioural insights to unlock real-world experiences.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData“By deploying the AiCure platform to our investigative sites, we create insights-enriched patient communities to advance clinical research.
“This collaboration reinforces our Dynamic Assembly philosophy where we join forces with the latest and most agile data and technology partners to address our customers’ needs.”
Under the strategic collaboration, Syneos Health can access AiCure’s digital biomarker assessments that evaluate facial, speech, and movement variables to study clinical endpoints.
AiCure’s technology directly fits into the dosing interaction with the study participant, while keeping all data of the study secured and protected.
Syneos’ sponsors and site staff can also access AiCure’s dashboards to enhance decision-making and achieve greater operational efficiencies in clinical trials.
AiCure CEO Alistair Macdonald said: “The AiCure platform aligns with our unique product development model that harnesses behavioural insights to unlock real-world experiences.
“By deploying the AiCure platform to our investigative sites, we create insights-enriched patient communities to advance clinical research.
“This collaboration reinforces our dynamic assembly philosophy where we join forces with the latest and most agile data and technology partners to address our customers’ needs.”
